Hemoglobinopathies Market Size, Share, Analysis, Trends, Growth, Forecasts 2032

Hemoglobinopathies Market by Indication (sickle cell disease, alpha thalassemia, beta thalassemia and others), Therapy (blood transfusion, iron chelation therapy, bone marrow transplant, and others), Diagnosis (blood testing, genetic testing, pre-implantation genetic diagnosis (PGD) and others), End user (Hospitals, Diagnostic laboratories, Clinics, Other End-user), and By Region - Global Industry Perspective Comprehensive Analysis and Forecast, 2024-2032

Category: Healthcare Report Format : PDF Pages: 205 Report Code: ZMR-4918 Published Date: Aug-2024 Status : Published

Market Size in 2023	Market Forecast in 2032	CAGR (in %)	Base Year
USD 9.63 Billion	USD 27.81 Billion	12.5%	2023

Table Of Content

Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
  - 1.3.1. Market Research Process
  - 1.3.2. Market Research Methodology
Chapter 2. Executive Summary
- 2.1. Hemoglobinopathies Market, 2016-2025 (USD Million)
- 2.2. Hemoglobinopathies Market: Snapshot
Chapter 3. Hemoglobinopathies Market - Industry Analysis
- 3.1. Hemoglobinopathies Market: Market Dynamics
- 3.2. Market Drivers
  - 3.2.1. Driver 1
  - 3.2.2. Driver 2
- 3.3. Restraints
  - 3.3.1. Restraint 1
  - 3.3.2. Restraint 2
- 3.4. Opportunity
  - 3.4.1. Government funding and support
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
  - 3.6.1. Market attractiveness analysis By Indication
  - 3.6.2. Market attractiveness analysis By Therapy
  - 3.6.3. Market attractiveness analysis By Diagnosis
  - 3.6.4. Market attractiveness analysis By End-user
  - 3.6.5. Market attractiveness analysis by Region
Chapter 4. Hemoglobinopathies Market- Competitive Landscape
- 4.1. Company market share analysis
  - 4.1.1. Global Hemoglobinopathies Market: company market share, 2018
- 4.2. Strategic development
  - 4.2.1. Acquisitions & mergers
  - 4.2.2. New Indication launches
  - 4.2.3. Agreements, partnerships, collaborations and joint ventures
  - 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
Chapter 5. Global Hemoglobinopathies Market -Indication Analysis
- 5.1. Global Hemoglobinopathies Market overview: By Indication type
  - 5.1.1. Global Hemoglobinopathies Market share, By Indication,2018 and 2025
- 5.2. Sickle cell disease
  - 5.2.1. Global Hemoglobinopathies Market by Sickle cell disease, 2016-2025 (USD Million)
- 5.3. Alpha Thalassemia
  - 5.3.1. Global Hemoglobinopathies Market by Alpha Thalassemia, 2016-2025 (USD Million)
- 5.4. Beta Thalassemia
  - 5.4.1. Global Hemoglobinopathies Market by Beta Thalassemia, 2016-2025 (USD Million)
- 5.5. Others
  - 5.5.1. Global Hemoglobinopathies Market by others, 2016-2025 (USD Million)
Chapter 6. Global Hemoglobinopathies Market -Therapy Analysis
- 6.1. Global Hemoglobinopathies Market overview: By Therapy
  - 6.1.1. Global Hemoglobinopathies Market share, By Therapy, 2018 and 2025
- 6.2. Blood Transfusion
  - 6.2.1. Global Hemoglobinopathies Market By Blood Transfusion, 2016-2025 (USD Million)
- 6.3. Iron Chelation Therapy
  - 6.3.1. Global Hemoglobinopathies Market By Iron Chelation Therapy, 2016-2025 (USD Million)
- 6.4. Bone Marrow Transplant
  - 6.4.1. Global Hemoglobinopathies Market By Bone Marrow Transplant, 2016-2025 (USD Million)
- 6.5. Others
  - 6.5.1. Global Hemoglobinopathies Market by Other Therapys, 2016-2025 (USD Million)
Chapter 7. Global Hemoglobinopathies Market -Diagnosis Analysis
- 7.1. Global Hemoglobinopathies Market overview: By Diagnosis
  - 7.1.1. Global Hemoglobinopathies Market share, By Diagnosis, 2018 and 2025
- 7.2. Blood testing
  - 7.2.1. Global Hemoglobinopathies Market by Blood testing, 2016-2025 (USD Million)
- 7.3. Genetic testing
  - 7.3.1. Global Hemoglobinopathies Market by Genetic testing, 2016-2025 (USD Million)
- 7.4. Pre-implantation Genetic Diagnosis (PGD)
  - 7.4.1. Global Hemoglobinopathies Market by Pre-implantation Genetic Diagnosis (PGD), 2016-2025 (USD Million)
- 7.5. Others
  - 7.5.1. Global Hemoglobinopathies Market by Diagnosis others, 2016-2025 (USD Million)
Chapter 8. Global Hemoglobinopathies Market - End-user Analysis
- 8.1. Global Hemoglobinopathies Market overview: By End-user
  - 8.1.1. Global Hemoglobinopathies Market share, By End-user, 2018 and 2025
- 8.2. Hospitals
  - 8.2.1. Global Hemoglobinopathies Market by Hospitals, 2016-2025 (USD Million)
- 8.3. Diagnostic laboratories
  - 8.3.1. Global Hemoglobinopathies Market by Diagnostic laboratories, 2016-2025 (USD Million)
- 8.4. Clinics
  - 8.4.1. Global Hemoglobinopathies Market by Clinics, 2016-2025 (USD Million)
- 8.5. Others
  - 8.5.1. Global Hemoglobinopathies Market by End-user Others, 2016-2025 (USD Million)
Chapter 9. Global Hemoglobinopathies Market - Regional Analysis
- 9.1. Global Hemoglobinopathies Market overview: by Region
  - 9.1.1. Global Hemoglobinopathies Market share, by Region, 2018 and 2025
- 9.2. North America
  - 9.2.1. North America Hemoglobinopathies Market, 2016-2025 (USD Million)
  - 9.2.2. North America Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
  - 9.2.3. North America Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
  - 9.2.4. North America Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
  - 9.2.5. North America Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.2.6. The U.S.
    - 9.2.6.1. The U.S. Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.2.6.2. The U.S. Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.2.6.3. The U.S. Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.2.6.4. The U.S. Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.2.7. Rest of North America
    - 9.2.7.1. Rest of North America Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.2.7.2. Rest of North America Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.2.7.3. Rest of North America Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.2.7.4. Rest of North America Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
- 9.3. Europe
  - 9.3.1. Europe Hemoglobinopathies Market, 2016-2025 (USD Million)
  - 9.3.2. Europe Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
  - 9.3.3. Europe Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
  - 9.3.4. Europe Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
  - 9.3.5. Europe Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.3.6. UK
    - 9.3.6.1. U.K. Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.3.6.2. U.K. Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.3.6.3. U.K. Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.3.6.4. U.K. Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.3.7. France
    - 9.3.7.1. France Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.3.7.2. France Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.3.7.3. France Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.3.7.4. France Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.3.8. Germany
    - 9.3.8.1. Germany Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.3.8.2. Germany Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.3.8.3. Germany Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.3.8.4. Germany Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.3.9. Rest of Europe
    - 9.3.9.1. Rest of Europe Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.3.9.2. Rest of Europe Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.3.9.3. Rest of Europe Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.3.9.4. Rest of Europe Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
- 9.4. Asia Pacific
  - 9.4.1. Asia Pacific Hemoglobinopathies Market, 2016-2025 (USD Million)
  - 9.4.2. Asia Pacific Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
  - 9.4.3. Asia Pacific Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
  - 9.4.4. Asia Pacific Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
  - 9.4.5. Asia Pacific Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.4.6. China
    - 9.4.6.1. China Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.4.6.2. China Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.4.6.3. China Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.4.6.4. China Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million
  - 9.4.7. Japan
    - 9.4.7.1. Japan Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.4.7.2. Japan Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.4.7.3. Japan Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.4.7.4. Japan Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.4.8. India
    - 9.4.8.1. India Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.4.8.2. India Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.4.8.3. India Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.4.8.4. India Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.4.9. Rest of Asia Pacific
    - 9.4.9.1. Rest of Asia Pacific Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.4.9.2. Rest of Asia Pacific Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.4.9.3. Rest of Asia Pacific Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.4.9.4. Rest of Asia Pacific Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
- 9.5. Latin America
  - 9.5.1. Latin America Hemoglobinopathies Market, 2016-2025 (USD Million)
  - 9.5.2. Latin America Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
  - 9.5.3. Latin America Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
  - 9.5.4. Latin America Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
  - 9.5.5. Latin America Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.5.6. Brazil
    - 9.5.6.1. Brazil Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.5.6.2. Brazil Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.5.6.3. Brazil Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.5.6.4. Brazil Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
  - 9.5.7. Rest of LatinAmerica
    - 9.5.7.1. Rest of LatinAmerica Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
    - 9.5.7.2. Rest of LatinAmerica Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
    - 9.5.7.3. Rest of Latin America Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
    - 9.5.7.4. Rest of Latin America Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
- 9.6. The Middle East and Africa
  - 9.6.1. The Middle East and Africa Hemoglobinopathies Market, 2016-2025 (USD Million)
  - 9.6.2. The Middle East and Africa Hemoglobinopathies Market revenue, By Indication,2016-2025 (USD Million)
  - 9.6.3. The Middle East and Africa Hemoglobinopathies Market revenue, By Therapy, 2016-2025 (USD Million)
  - 9.6.4. The Middle East and Africa Hemoglobinopathies Market revenue, By Diagnosis, 2016-2025 (USD Million)
  - 9.6.5. The Middle East and Africa Hemoglobinopathies Market revenue, By End-user, 2016-2025 (USD Million)
Chapter 10. Company Profiles
- 10.1. Alnylam Pharmaceuticals
  - 10.1.1. Overview
  - 10.1.2. Financials
  - 10.1.3. Indication Portfolio
  - 10.1.4. Business Strategy
  - 10.1.5. Recent Developments
- 10.2. bluebird bio Inc.
  - 10.2.1. Overview
  - 10.2.2. Financials
  - 10.2.3. Indication Portfolio
  - 10.2.4. Business Strategy
  - 10.2.5. Recent Developments
- 10.3. Celgene Corporation
  - 10.3.1. Overview
  - 10.3.2. Financials
  - 10.3.3. Indication Portfolio
  - 10.3.4. Business Strategy
  - 10.3.5. Recent Developments
- 10.4. Emmaus Life Sciences Inc.
  - 10.4.1. Overview
  - 10.4.2. Financials
  - 10.4.3. Indication Portfolio
  - 10.4.4. Business Strategy
  - 10.4.5. Recent Developments
- 10.5. Gamida Cell
  - 10.5.1. Overview
  - 10.5.2. Financials
  - 10.5.3. Indication Portfolio
  - 10.5.4. Business Strategy
  - 10.5.5. Recent Development
- 10.6. Global Blood Therapeutics
  - 10.6.1. Overview
  - 10.6.2. Financials
  - 10.6.3. Indication Portfolio
  - 10.6.4. Business Strategy
  - 10.6.5. Recent Development
- 10.7. Prolong Pharmaceuticals
  - 10.7.1. Overview
  - 10.7.2. Financials
  - 10.7.3. Indication Portfolio
  - 10.7.4. Business Strategy
  - 10.7.5. Recent Development
- 10.8. Sangamo
  - 10.8.1. Overview
  - 10.8.2. Financials
  - 10.8.3. Indication Portfolio
  - 10.8.4. Business Strategy
  - 10.8.5. Recent Development
- 10.9. Therapeutics Inc.
  - 10.9.1. Overview
  - 10.9.2. Financials
  - 10.9.3. Indication Portfolio
  - 10.9.4. Business Strategy
  - 10.9.5. Recent Development
- 10.10. Sanofi
  - 10.10.1. Overview
  - 10.10.2. Financials
  - 10.10.3. Indication Portfolio
  - 10.10.4. Business Strategy
  - 10.10.5. Recent Development